Biomaterials legislation passed by US Congress in race against the clock
This article was originally published in Clinica
Executive Summary
The US Congress last week passed one of the medical device industry's top legislative priorities - a bill protecting biomaterial suppliers from frivolous product liability lawsuits involving allegedly faulty implantable medical devices.